Genomic Health (NASDAQ: GHDX) reported Q1 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $83.98 million versus the consensus estimate of $86.19 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.